Citation Impact
Citing Papers
Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotype
2007 Standout
Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial.
1988
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
2009 Standout
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement
2015 Standout
Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence
2007 Standout
Carbonic anhydrase XII is a marker of good prognosis in invasive breast carcinoma
2003 StandoutNobel
Prognostic value of genomic alterations in minimal residual cancer cells purified from the blood of breast cancer patients
2000
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Occult axillary node metastases in breast cancer: their detection and prognostic significance
1996
Simultaneous Foxp3 and IDO expression is associated with sentinel lymph node metastases in breast cancer
2009
Younger women with breast carcinoma have a poorer prognosis than older women
1996
The detection of ductal carcinoma in situ at mammographic screening enables the diagnosis of small, grade 3 invasive tumours
1997
The Influence of Margin Width on Local Control of Ductal Carcinoma in Situ of the Breast
1999
Predicting the Status of the Nonsentinel Axillary Nodes
2001
Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes
1997 Standout
A prognostic index for ductal carcinoma in situ of the breast
1996
Prognostic significance of occult lymph node metastases in node-negative breast cancer
1997
The Nottingham prognostic index in primary breast cancer
1992
A Randomized Comparison of Sentinel-Node Biopsy with Routine Axillary Dissection in Breast Cancer
2003 Standout
Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual
2003
Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial
1999
Dissemination and growth of cancer cells in metastatic sites
2002 Standout
Trends in the Treatment of Ductal Carcinoma In Situ of the Breast
2004
Genetic instabilities in human cancers
1998 StandoutNature
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
2004 Standout
Users' Guides to the Medical Literature
1999 Standout
Recurrence Rates after Treatment of Breast Cancer with Standard Radiotherapy with or without Additional Radiation
2001 Standout
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
2004 Standout
Histologic types and hormone receptors in breast cancer in men: a population-based study in 282 United States men
1993
Patterns of Axillary Surgical Care for Breast Cancer in the Era of Sentinel Lymph Node Biopsy
2008
Prognostic Value of Residual Node Involvement in Operable Breast Cancer after Induction Chemotherapy
2002
Twenty-Year Follow-up of a Randomized Study Comparing Breast-Conserving Surgery with Radical Mastectomy for Early Breast Cancer
2002 Standout
Socioeconomic factors and breast cancer in black and white Americans
2003
Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast Cancer
2002 Standout
Extended Lymph-Node Dissection for Gastric Cancer
1999 Standout
Differences in physician prevention practice patterns for white and minority patients
1988
Primary Care Physicians Who Treat Blacks and Whites
2004 Standout
Pathological prognostic factors in breast cancer
1999 Standout
Prognostic value of bone marrow biopsy in operable breast cancer patients at the time of initial diagnosis: Results of a 20-year median follow-up
1998
Lumpectomy Compared with Lumpectomy and Radiation Therapy for the Treatment of Intraductal Breast Cancer
1993
Levels of Hypoxia-Inducible Factor-1 During Breast Carcinogenesis
2001 StandoutNobel
Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer
2010 Standout
Ductal Carcinoma In Situ, Complexities and Challenges
2004
The microenvironment of the tumour–host interface
2001 StandoutNature
Expression of the Hypoxia-Inducible and Tumor-Associated Carbonic Anhydrases in Ductal Carcinoma in Situ of the Breast
2001 StandoutNobel
Male breast cancer
2006 Standout
Black/white differences in type of initial breast cancer treatment and implications for survival.
1987
Early Onset of Breast Carcinoma in African American Women With Poor Prognostic Factors
1999
A prognostic score in histological node negative breast cancer
1990
Axillary lymph node dissection for t1a breast carcinoma. Is it indicated?
1994
The risk of liver neoplasia in relation to combined oral contraceptive use
1991
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
2011 Standout
Impact of axillary lymph node dissection on the therapy of breast cancer patients.
1993
Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis
2011 Standout
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
2004 Standout
Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1‐related breast carcinoma
2003
Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases
1989 Standout
Lymphatic Mapping and Sentinel Lymphadenectomy for Breast Cancer
1994 Standout
Sentinel-Lymph-Node Biopsy for Breast Cancer — Not Yet the Standard of Care
1998
Breast cancer metastasis: markers and models
2005 Standout
Age as prognostic factor in premenopausal breast carcinoma
1993
Ductal carcinoma in situ of the breast
1997
The prognosis of breast cancer in males a report of 335 cases
1993
Lymphatic Mapping and Sentinel Node Biopsy in the Patient With Breast Cancer
1996 Standout
Prognostic significance of number and level of axillary node metastases in breast cancer
1993
Five-Year Results of a Randomized Clinical Trial Comparing Total Mastectomy and Segmental Mastectomy with or without Radiation in the Treatment of Breast Cancer
1985 Standout
Molecular insights into cancer invasion: strategies for prevention and intervention.
1995
Prooxidant States and Tumor Promotion
1985 StandoutScience
Revision of the American Joint Committee on Cancer Staging System for Breast Cancer
2002
Risk Factors for Breast Cancer in Women with Proliferative Breast Disease
1985 Standout
Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement
2016 Standout
American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer
2005 Standout
Distribution of axillary node metastases by level of invasion. An analysis of 539 cases
1987
Natural history of hepatocellular carcinoma and prognosis in relation to treatment study of 850 patients
1985 Standout
Race and socio-economic status in survival from breast cancer
1982
Clinical decision-making in early breast cancer.
1993
Lymph Node Metastases
1984
Sentinel Lymph Node Biopsy for Breast Cancer: A Suitable Alternative to Routine Axillary Dissection in Multi-Institutional Practice When Optimal Technique Is Used
2000
Prognostic Variables in Male Breast Cancer
2000
Comparative study of the histopathology of breast cancer in a screened and unscreened population investigated by mammography
1985
Resection of primary solid hepatic tumors
1981
Spontaneous rupture of a liver cell adenoma after long term Methyltestosterone: Report of a case successfully treated by emergency right hepatic lobectomy
1979
The stages of initiation and promotion in hepatocarcinogenesis
1980
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
2007 Standout
Discontinuous or “Skip” Metastases in Breast Carcinomae: Analysis of 1228 Axillary Dissections
1983
Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis
2017 Standout
Minimal breast cancer. An update
1984
Probability of false negative nodal staging in conjunction with partial axillary dissection in breast cancer
1985
Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy
2007 Standout
Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma
1999 Standout
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Serum CA 15.3, CEA and ESR Patterns in Breast Cancer
1997
Axillary lymph node dissection for intraductal breast carcinoma-is it indicated?
1987
Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline
2017 Standout
Metaplastic Breast Cancer: Clinical Features and Outcomes
2005
Long-term survival and prognostic factors in patients with regional breast cancer (skin, muscle, and/or chest wall attachment)
1985
Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis
2006 Standout
X-Tile
2004 Standout
The pathologic findings of breast cancer in patients surviving 25 years after radical mastectomy
1982
Standards for breast-conservation treatment
1992
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4
2013 StandoutNobel
Intraductal carcinoma of the breast: Follow-up after biopsy only
1982
The surgeon's role in primary breast cancer
1981
Actual Causes of Death in the United States
1993 Standout
Breast Cancer in Men
2002 Standout
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
2004 Standout
Works of J Vána being referenced
Breast cancer in the medial half. Results of 1978 national survey of the American College of surgeons
1983
Management and survival of female breast cancer: Results of a national survey by the American college of surgeons
1980
Noninvasive Breast Carcinoma
1980
Primary Liver Tumors and Oral Contraceptives
1977
Management and survival of female patients with “minimal” breast cancer: As observed in the long-term and short-term surveys of the american college of surgeons
1981
Observations on short-term and long-term surveys of breast cancer by the American College of Surgeons. I. Significance of the number of axillary nodes and II. Estrogen receptor assay in the U.S. in 1977.
1981
Trends in diagnosis and management of breast cancer in the U. S.: From the surveys of the american college of surgeons
1981
The histology of liver tumors in oral contraceptive users observed during a national survey by the American College of Surgeons Commission on cancer
1979
Survey of primary liver tumors and oral contraceptive use
1979